Close Menu
Health Care Today
  • Home
  • News
  • Fitness
  • Nutrition
  • Skin Care
  • Women’s Health
  • More
    • Mental Well-Being
    • Sexual Health
    • Press Release
    • Editor’s Picks
What's On
Meet the Teen Who Called a Hospital Home

Meet the Teen Who Called a Hospital Home

November 18, 2026
Trump Administration OKs Native Traditional Healing for Two States’ Medicaid Programs

Trump Administration OKs Native Traditional Healing for Two States’ Medicaid Programs

November 18, 2026
Moving to a New State? Your Healthcare Might Get More Complicated

Moving to a New State? Your Healthcare Might Get More Complicated

November 17, 2026
‘A Hard Time’ as Federal Cuts Hobble Efforts To Stop Overdoses From Tainted Drugs

‘A Hard Time’ as Federal Cuts Hobble Efforts To Stop Overdoses From Tainted Drugs

November 17, 2026
These Governors-Elect Campaigned on Expanding Medicaid. It Won’t Be Easy.

These Governors-Elect Campaigned on Expanding Medicaid. It Won’t Be Easy.

November 16, 2026
Facebook X (Twitter) Instagram
Health Care Today
  • Home
  • News
  • Fitness
  • Nutrition
  • Skin Care
  • Women’s Health
  • More
    • Mental Well-Being
    • Sexual Health
    • Press Release
    • Editor’s Picks
Subscribe
Health Care Today
Home » Trump Bought Stock in Eli Lilly as His Policies Gave the Drugmaker a Big Boost, Documents Show
Blog

Trump Bought Stock in Eli Lilly as His Policies Gave the Drugmaker a Big Boost, Documents Show

staffBy staffMay 23, 2026
Facebook Twitter Pinterest LinkedIn Email Telegram WhatsApp Copy Link
Trump Bought Stock in Eli Lilly as His Policies Gave the Drugmaker a Big Boost, Documents Show

President Donald Trump has long bantered about GLP-1s, the breakthrough medicines that have changed care for diabetes and obesity. Sometimes he calls them “the fat drug.” In an interview with the The New York Times in January, he mused that “I probably should” take them.

A few days before the Times published that story, Trump invested in Eli Lilly, the nearly $1 trillion drugmaker whose fortunes are closely tied to its blockbuster GLP-1s, Zepbound and Foundayo — and to government reimbursement for the medicines.

This week we reported on several Lilly stock purchases made by Trump or his brokers from January to March, totaling as much as $680,000, according to a disclosure signed by the president. He also purchased stock worth $250,000 to $500,000 in West Pharmaceutical Services, a company that manufactures devices for injectable drugs. It, too, is benefiting from the GLP-1 surge. 

As the purchases occurred, the Trump administration was undertaking an agenda that boosted the GLP-1 market, including advancing Medicare reimbursement for the drugs to treat obesity, a long-held goal for Lilly. The deadline for drug manufacturers to get involved in a reimbursement project was Jan. 8. 

The administration also intensified a crackdown on “compounded” GLP-1s — cheaper, copycat medications made by pharmacies that critics (and brand-name drugmakers) claim are unsafe. That knocked out competitors to Lilly’s products. Trump’s FDA also rapidly approved Lilly’s GLP-1 pill, Foundayo. 

Email Sign-Up

Subscribe to KFF Health News’ free weekly newsletter, “The Week in Brief.”

The timing of the Lilly purchases — among more than 3,600 trades Trump or his representatives made in the first quarter of the year — troubled government ethics experts. 

“A president who buys or sells the stock of a company whose value is affected by his administration’s actions undermines the public’s trust in two ways,” said Kathleen Clark, a legal ethicist at Washington University in St. Louis.

First, she said, the public should believe government actions are motivated by common good, not personal enrichment. Second, the public should believe that those within government aren’t benefiting from inside information.

The disclosures have also intensified criticism from Trump opponents who say he’s trying to profit from the presidency.

Congressional Democrats are calling for legislative action. “Trump is the ultimate con man — rig the game, manipulate the rules, and reap the benefits,” Sen. Andy Kim (D-N.J.) said on X, highlighting our report. “It’s long past time we ban presidents from owning and trading stocks.”  

Democrats might have their shot at a bill in 2027. Public opinion is increasingly swinging in their direction, and taking both chambers of Congress is a possibility. (Of course, even if Democrats claimed those majorities and passed a bill, it would have to be signed by Trump.) If they were determined to pursue anti-corruption measures relating to health issues, they would have targets beyond Trump’s stock trading. Democrats have also questioned corporate contributors’ influence on changes in FDA tobacco regulation, for example. 

New ethics disclosures show the president invested in Eli Lilly and a company that manufactures injectable devices as his health agencies implemented policies that benefited them.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Articles

Meet the Teen Who Called a Hospital Home

Meet the Teen Who Called a Hospital Home

November 18, 2026
Trump Administration OKs Native Traditional Healing for Two States’ Medicaid Programs

Trump Administration OKs Native Traditional Healing for Two States’ Medicaid Programs

November 18, 2026
Moving to a New State? Your Healthcare Might Get More Complicated

Moving to a New State? Your Healthcare Might Get More Complicated

November 17, 2026
Top Articles
Xiaomi Phones Can Now Add Extra Storage With Some Magic

Xiaomi Phones Can Now Add Extra Storage With Some Magic

January 9, 2020
Ways by Which Your Partner Impacts Your Life: Therapist Explains

Ways by Which Your Partner Impacts Your Life: Therapist Explains

January 8, 2020
Mobile Calls Associated With Risk of High Blood Pressure

Mobile Calls Associated With Risk of High Blood Pressure

January 6, 2020
Review: 7 Future Fashion Trends Shaping the Future of Fashion

Review: 7 Future Fashion Trends Shaping the Future of Fashion

January 10, 2020
Average Mobile Data Usage Now Exceeds 10GB Per Month

Average Mobile Data Usage Now Exceeds 10GB Per Month

January 5, 2020
Don't Miss
US Has Lost Measles Elimination Status, Global Health Authorities Say
Blog

US Has Lost Measles Elimination Status, Global Health Authorities Say

November 14, 2026

The U.S. has officially lost its status as a country where measles is eliminated, a…

It’s Open Enrollment Season. Hear Reporters Discuss ACA Sign-Ups, High Costs, and More.

It’s Open Enrollment Season. Hear Reporters Discuss ACA Sign-Ups, High Costs, and More.

November 14, 2026
Fed Up With the Healthcare Industry, This Red State Capped Insulin Prices for Patients

Fed Up With the Healthcare Industry, This Red State Capped Insulin Prices for Patients

November 13, 2026
Medicaid Work Rules Don’t Apply to Native Americans. They Could Still Lose Coverage.

Medicaid Work Rules Don’t Apply to Native Americans. They Could Still Lose Coverage.

November 13, 2026
  • Privacy Policy
  • Terms of use
  • Contact
© 2026 Health Care Today. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.